1.4757

1.01% -0.0143

Alx Oncology Holdings Inc (ALXO)

Overview News Price History Option Chain Financials Discussions Forecast

Alx Oncology Holdings Inc stock is traded at $1.4757, with a volume of 240.64K. It is down -1.01% in the last 24 hours and down -12.20% over the past month. ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Previous Close:

$1.49

Open:

$1.48

24h Volume:

240.64K

Relative Volume:

0.32

Market Cap:

$79.27M

Revenue:

Net Income/Loss:

$-160.81M

P/E Ratio:

-0.4612

EPS:

-3.2

Net Cash Flow:

$-131.64M

1W Performance:

+5.36%

1M Performance:

-12.20%

6M Performance:

-90.40%

1Y Performance:

-82.27%

1-Day Range:

$1.4462

$1.52

1-Week Range:

$1.335

$1.565

52-Week Range:

$1.335

$17.82

Alx Oncology Holdings Inc Stock (ALXO) Company Profile

Name

Alx Oncology Holdings Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

650-466-7125

Address

323 ALLERTON AVENUE, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

ALXO's Discussions on Twitter

Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-08-23	Upgrade	Jefferies	Hold → Buy
Dec-22-21	Downgrade	Jefferies	Buy → Hold
Sep-30-21	Initiated	Stifel	Buy
May-05-21	Resumed	Credit Suisse	Outperform
Apr-26-21	Resumed	Credit Suisse	Outperform
Apr-06-21	Initiated	UBS	Buy
Feb-10-21	Initiated	H.C. Wainwright	Buy
Aug-11-20	Initiated	Cantor Fitzgerald	Overweight
Aug-11-20	Initiated	Credit Suisse	Outperform
Aug-11-20	Initiated	Jefferies	Buy
Aug-11-20	Initiated	Piper Sandler	Overweight

View All

Alx Oncology Holdings Inc Stock (ALXO) Latest News

Nov 04, 2024

ALX Oncology Announces November Investor Conference Participation - GlobeNewswire

Nov 04, 2024

Nov 03, 2024

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Nov 03, 2024

Nov 02, 2024

ALXOALX Oncology Holdings Inc. Latest Stock News & Market Updates - StockTitan

Nov 02, 2024

Nov 01, 2024

ALX Oncology Announces Results from Phase 1b/2 Trial of - GlobeNewswire

Nov 01, 2024

ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024 - StockTitan

Nov 01, 2024

Oct 30, 2024

ALXO stock touches 52-week low at $1.42 amid market challenges - Investing.com Australia

Oct 30, 2024

Oct 29, 2024

ALXO stock touches 52-week low at $1.42 amid market challenges By Investing.com - Investing.com South Africa

Oct 29, 2024

SG Americas Securities LLC Has $50,000 Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Oct 29, 2024

Oct 16, 2024

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Down 6.7% in September - MarketBeat

Oct 16, 2024

Oct 14, 2024

Technical analysis of Alx Oncology Holdings Inc (ALXO) stock chart patterns - US Post News

Oct 14, 2024

Oct 11, 2024

ALXO Stock: A Comprehensive Analysis and Forecast - The InvestChronicle

Oct 11, 2024

Closing Figures: Alx Oncology Holdings Inc (ALXO)’s Negative Finish at 1.44, Down -11.11 - The Dwinnex

Oct 11, 2024

SVP, FINANCE AND CAO Pinto Shelly sale 564 shares of Alx Oncology Holdings Inc [ALXO] - Knox Daily

Oct 11, 2024

Oct 10, 2024

Millennium Management LLC Reduces Stake in ALX Oncology Holdings Inc - Yahoo Finance

Oct 10, 2024

ALXO stock touches 52-week low at $1.55 amid market challenges By Investing.com - Investing.com South Africa

Oct 10, 2024

ALXO stock touches 52-week low at $1.55 amid market challenges - Investing.com

Oct 10, 2024

Oct 09, 2024

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives $12.20 Average PT from Brokerages - MarketBeat

Oct 09, 2024

Oct 06, 2024

ALX Oncology Holdings Drops To US$1.68, Yet Insiders May Have Sold Too Early - Simply Wall St

Oct 06, 2024

Oct 05, 2024

American Century Companies Inc. Cuts Stake in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Oct 05, 2024

Oct 04, 2024

A company insider recently sold 564 shares of Alx Oncology Holdings Inc [ALXO]. Should You Sale? - Knox Daily

Oct 04, 2024

ALX Oncology Chief Medical Officer resigns, search for replacement begins - Investing.com India

Oct 04, 2024

Point72 Asset Management L.P. Makes New $1.83 Million Investment in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Oct 04, 2024

ALX Oncology CMO Sophia Randolph Announces Resignation - TipRanks

Oct 04, 2024

ALX Oncology Chief Medical Officer resigns, search for replacement begins By Investing.com - Investing.com UK

Oct 04, 2024

ALX Oncology Holdings Inc. Announces Resignation of Sophia Randolph as Chief Medical Officer, Effective October 11, 2024 - Marketscreener.com

Oct 04, 2024

Point72 Asset Management L.P. Acquires New Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - MarketBeat

Oct 04, 2024

Oct 03, 2024

ALXO stock touches 52-week low at $1.75 amid market challenges By Investing.com - Investing.com South Africa

Oct 03, 2024

ALXO stock touches 52-week low at $1.75 amid market challenges - Investing.com

Oct 03, 2024

Marshall Wace LLP Has $3.83 Million Stake in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Oct 03, 2024

Oct 02, 2024

You might want to take a look at Alx Oncology Holdings Inc (ALXO) now - SETE News

Oct 02, 2024

Renaissance Technologies LLC Increases Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Oct 02, 2024

Oct 01, 2024

Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.

Oct 01, 2024

ALXO’s 2023 Market Dance: Down -87.78% – Time to Invest? - The InvestChronicle

Oct 01, 2024